- Clinical Trials
- April 2025
- 40 Pages
Global
From €1109EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1109EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1109EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1109EUR$1,250USD£966GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1109EUR$1,250USD£966GBP
- Report
- December 2024
- 30 Pages
Global
From €2883EUR$3,250USD£2,511GBP
- Report
- March 2024
- 200 Pages
Global
From €3682EUR$4,150USD£3,206GBP
- Report
- January 2026
- 70 Pages
Indonesia
From €4214EUR$4,750USD£3,670GBP
- Report
- May 2025
- 70 Pages
Japan
From €4214EUR$4,750USD£3,670GBP
- Report
- July 2024
- 70 Pages
Brazil
From €4214EUR$4,750USD£3,670GBP
- Report
- July 2024
- 70 Pages
Global
From €4214EUR$4,750USD£3,670GBP
- Report
- July 2024
- 70 Pages
Global
From €4214EUR$4,750USD£3,670GBP
- Report
- February 2024
- 70 Pages
United States
From €4214EUR$4,750USD£3,670GBP
- Report
- February 2024
- 70 Pages
China
From €4214EUR$4,750USD£3,670GBP
- Report
- February 2024
- 70 Pages
Thailand
From €4214EUR$4,750USD£3,670GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more